Sormani MP, Häring DA, Kropshofe H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, #277.
ECTRIMS 2015 video update Zwanikken: Parallel Session 5 Personalized therapy
jun 2017